Testing for polymorphisms of KCNJ11, UCP2, and MTHFR, which are directly involved in the metabolism of glucose, homocysteine (Hcy), and insulin synthesis, is fundamentally important for predicting the risk of T2D and its vascular complications and their prevention [10-13]. This evidence concerns the gene UCP2 and type 2 diabetes mellitus.